[Influence of nitrostigmine poisoning and specific antidotal  therapy with Obidoxime on bilirubin clearance and bile flow in rats].
D000818:Animals; D000931:Antidotes / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D001646:Bile / Q000378:metabolism*; D001663:Bilirubin / Q000097:blood / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000037:antagonists & inhibitors*; D005260:Female; D000860:Hypoxia / Q000139:chemically induced; D010278:Parathion / Q000633:toxicity*; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D051381:Rats
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D011220:Pralidoxime Compounds; D010278:Parathion; D001285:Atropine; D001663:Bilirubin
Der Einfluss der Nitrostigmin-Vergiftung und der spezifischen Antidot-Therapie mit Obidoxin auf die Bilirubin-Clearance und den Gallefuss der Ratte.